Feeds:
Posts
Comments

Posts Tagged ‘vaccine supply’

Vaccinestamp

“Delays in the release of H1N1 flu shots show that the United States is too dependent on other countries for the manufacture of vaccines and that the technology to make them must be improved,” said HHS Secretary Kathleen Sebelius. http://www.google.com/hostednews/ap/article/ALeqM5hDG1Y2pO9MZlJLNboKJOSSY9xWTwD9BFOG0O4 

Oh shut up.  Sebelius is appealing for more money for the pharmaceutical industry plain and simple, and is doing so at the risk of every single man, woman, child animal, and insect population on Earth.   

The new strain of swine flu, A/H1N1 includes genetic material from swine, poultry and human variants, and underscores the contribution of high densities of farmed animals serving as Petri-dishes for the evolution of zoonotic diseases, compounded by human proximity, international travel, and trade, especially in live animals. The US government will spend $2 billion of public funds in contracting drug companies to fast-track vaccine production to combat this new influenza strain, a policy decision based on fear and ignorance, if not also pandering to corporate interests regardless of the potential risks, questionable need and effectiveness of such a vaccine. Vaccinations will be given without adequate testing for safety and effectiveness, and the Government has ruled that manufacturers are immune from law suits over adverse reactions. Michael W. Fox  BVetMed, PhD, DSc, MRCVS http://www.twobitdog.com/DrFox/specialreport_Article.aspx?ID=ffaa40af-5973-400d-9655-e25eec3d946e

Sebelius knows damned well that vaccine technology does exists for an updated vaccine-making process.   The problem comes from the lies of  governments on how vaccines are currently made and opening Pandora’s box of mutated viruses.  

 st judes

This patent won approval in 1998, outlining a a  means of vaccine development…  http://www.patentstorm.us/patents/5824536/description.html  and pdf a thttp://www.patentstorm.us/patents/pdfs/patent_id/5824536.html from the Saint Jude Children’s Research Hospital:

At present, many viral vaccines other than influenza are produced using primary trypsinized cells, including cells from monkey kidneys, and the kidneys of rabbits and hamsters. Primary diploid cell (sic- aborted fetus) cultures have certain advantages such as easy preparation using simple media and bovine sera and sensitivity to a wide-range multiple viruses. However, primary diploid cells suffer from disadvantages, such as contamination by various adventitous agents, variable quality and sensitivity; and difficulty in obtaining suitable tissue for cultivation

For example, primary diploid cell cultures obtained from monkey kidneys of wild animals usually contain endogenous viruses.

Furthermore, only MDCK cells, (sic- dog kidney) among the continuous cell lines tested, have been reported to support potentially sufficient growth and isolation of viruses (Frank et al., J. Clin. Microb. 10:32-36 (1979); Schepetink & Kok, J. Virol. Methods 42:241-250 (1993)). However, this line has been found to produce tumors and has thus not been certified for vaccine production, as not substantially free of adventitious agents.

The technology exists.  The question arises, do you want to be injected with a virus that was grown in a mammal that is not human?  Have you already been injected with a vaccine that was cultivated from a mammal like the polio vaccine was?   Dr. Robert B. Strecker, M.D., Ph.D back in 1982 warned of AIDS and recombinant retroviruses like H1N1 in a report he called “The Bioalert Attack.”    https://ahrcanum.wordpress.com/2009/09/24/swine-flu-aids-vaccine-control-by-world-health-org/ 

But the fact is, you are not being told the truth by the government or the so-called AIDS experts. The media, for reasons of their own, will not present information contradicting the official propaganda. So you can choose to go along with the same people who gave us brain cancer (SV-40 virus) as a result of their contaminated polio vaccines in the early 1960’s, a polio-like disease from their contaminated Swine Flu Vaccine in the 1970’s; and AIDS from their smallpox and hepatitis B vaccines; or, you can at least make yourself aware of the clear and present dangers that we all face by watching The Strecker Memorandum. http://sonic.net/~doretk/ArchiveARCHIVE/Aids/6.Strecker%20Memo.html

 novartis

In one trial of Influenza A (H1N1) 2009 Monovalent MF59-Adjuvanted Vaccine- by Novartis http://content.nejm.org/cgi/content/full/NEJMoa0907650v1 

The seed virus was grown in Madin–Darby Canine Kidney (MDCK) cell culture by means of standard processes similar to those used for the development of Optaflu vaccines against interpandemic influenza. The vaccine was formulated and produced by Novartis (Marburg, Germany) as an inactivated surface-antigen H1N1 vaccine…Our vaccine was produced from a classical egg-derived seed virus propagated in a MDCK cell line..

Optaflu®  is the first influenza vaccine made in a mammalian cell line, rather than chicken eggs.

 Calling for approval of new technology calls into question the safety of using viruses in humans and other mammals as this study GM Vaccines Recombine into Unpredictable Hybrid shows the chaos that can be created when playing God.

 In what may be the first experiment of its kind, scientists infected cell cultures with two related viruses….  A single virus multiplied into hundreds of thousands of viruses in a few hours, with unpredictable consequences. Since the marker gene in the transgenic virus was not present in some of the newly formed hybrid viruses, it would not be possible to track transgenic viruses as the origin of the hybrids, if they were found in the wild.

“The kinds of viral research going on today, including applications in biowarfare, are primarily driven to develop new vaccines to market in the name of ‘preventive’ human and veterinary medicine. You didn’t think your pet was safe did you? What is injected into our farm animals for human consumption? Since the first vaccine was licensed in 1979, a total of 79 genetically engineered biologics have been licensed; all but 20 are still being produced.  Now there are 2,379 active product licenses for these animal vaccines and other biologics and 110 licensed manufacturers’.”  http://www.twobitdog.com/DrFox/specialreport_Article.aspx?ID=273f53f4-bcdc-474f-a189-cca1d1a81c38 

What about the ingredients that U.S. Vaccine suppliers have to adhere to, including the fact that no vaccine approved so far.(only thimerosal/mercury) will contain adjuvants like MF-59 in the U.S.?  In Canada, they are making special provisions for pregnant women to receive a non-adjuvanted vaccine while the rest of the population gets the adjuvanted one. http://www.cbc.ca/health/story/2009/10/16/ontario-pregnant-women-vaccine496.html?ref=rss The Swiss government is doing the same.  German soldiers will receive a different vaccine that contains no mercury or thimerosal- often linked to autism.https://ahrcanum.wordpress.com/2009/10/15/baxter-h1n1-vaccine-celvapan-to-german-soldiers/

The U.S. government has awarded a $487 million contract to Novartis for a plant in North Carolina that will make flu vaccine by growing the virus inside animal cells, preferably from mammals. The plant is expected to be up and running by 2011 or 2012. http://www.nytimes.com/2009/04/29/business/economy/29vaccine.html?_r=2&ref=health

 Also, Protein Sciences Corp. of Meriden, Conn., landed a five-year, $147 million contract to develop a vaccine using its recombinant technology — flu proteins grown in insect cells. The hope is that the first doses would be available within 12 weeks of the beginning of a pandemic. That is about twice as fast as flu vaccine produced from eggs.  Biotechnology company Vical Inc. said Thursday its developing swine flu vaccine prompted “robust” immune responses in 100 percent of animals infected with distinct strains of the virus.  Vical is developing its vaccine under an agreement with the U.S. Navy. It is currently working the U.S. Navy to secure funding in order to advance the vaccine candidate to human studies.http://blog.taragana.com/n/vical-says-its-developing-swine-flu-vaccine-prompts-immune-responses-in-mice-rabbits-164849/

“I think you’re going to see these new technologies come on board rapidly, especially given what’s happened this year,” said Paul Radspinner, president and chief executive of FluGen Inc., a Madison, Wis., company working on several new vaccine technologies of its own.http://blog.taragana.com/n/production-of-swine-flu-vaccine-is-way-behind-schedule-50-year-old-technology-is-blamed-202650/

The U.S. government and scientists are going  buggy!  To think that no one can figure why we are seeing cross species mutations in virus is absolutely asinine based on vaccine technology of intermingling cell species. 

“The only safe vaccine is one that is never used.—-No vaccine can be proven safe before it is given to children.”—statements by the late James A. Shannon, while serving as Director of the US National Institutes of Health.   

Related post https://ahrcanum.wordpress.com/2009/10/12/h1n1-swine-flu-vaccine-grown-in-dog-cells/

flag tounge

Open wide, say ahhh and check out these posts on the A/H1N1 Swine Flu from Ahrcanum, where the conspiracy spreads as fast as the virus itself. Subscribe for free in the top right margin.

https://ahrcanum.wordpress.com/swine-flu-report/

We do not provide medical advice, see your health care practitioner when appropriate. ® logos by respective owners.

Read Full Post »

The Centers for Disease Control(CDC) believes that up to 12 million fewer doses of H1N1 vaccine than expected will be available by month’s end. Availability will be limited for the next week or two due to manufacturing delays. The CDC had hoped 40 million doses would be available by end of October, but this is very unlikely. http://www.huliq.com/8059/87759/h1n1-swine-flu-production-slower-expected

2009 H1N1 Influenza Vaccine Supply Status

Aggregate Totals
Posted October 16, 2009, 12:00 PM ET
Doses Allocated as of 10/14/09* 11,422,900
Doses Ordered as of 10/14/09 7,971,800
Doses Shipped as of 10/14/09** 5,885,900
*Doses allocated to project areas for ordering are those that are at the distribution depots and ready for project areas to order.
Vaccine is allocated to each project area in proportion to its population (pro rata).

**There is a lag time between allocation, ordering, and shipment of doses as project areas place orders and those orders are processed and shipped.

Project areas reflect CDC Public Health Emergency Response (PHER) Grantees.

http://www.cdc.gov/h1n1flu/vaccination/vaccinesupply.htm

Dr. Anne Schuchat, CDC’s director of the National Center for Immunization and Respiratory Diseases reported on Friday that manufacturers are making unprecedented amounts of vaccine, but difficulties growing the vaccine, as well as time-consuming potency and purity testing, are contributing to the delay. “We are not cutting any corners in the safety of the production of the vaccine or the testing and oversight of the vaccine” Schuchat explained.

Let us explain. The 2009 H1N1 Vaccine should be labeled as toxic waste.  Here are the patient inserts on each of the approved vaccines in the U.S. https://ahrcanum.wordpress.com/2009/09/27/h1n1-swine-flu-vaccine-package-insert-warnings/  All were given fast track approval based on how previous seasonal vaccines were manufactured.  All have legal immunity from any lawsuits that might arise due to injury.  Quite simply, the CDC has cut corners.

 

flag tounge

Open wide, say ahhh and check out these posts on the A/H1N1 Swine Flu from Ahrcanum, where the conspiracy spreads as fast as the virus itself.

Opinions are like a$$holes, everyone has one.  SUBSCRIBE NOW to our opinions in the top right margin for updates.

https://ahrcanum.wordpress.com/swine-flu-report/

Read Full Post »